Are pleural fluid parameters related to the development of residual pleural thickening in tuberculosis?

Chest

Volumn 112, Issue 5, 1997, Pages 1293-1297

  De Pablo, Alicia ^a   Villena, Victoria ^a   Echave Sustaeta, José ^a   Encuentra, Angel López ^a  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

Author keywords

Lysozyme; Pleural inflammation; Pleural thickening; Pleural tuberculosis; Tumor necrosis factor

Indexed keywords

GLUCOSE; LYSOZYME; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; AGED; ARTICLE; FEMALE; HUMAN; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; PH MEASUREMENT; PLEURA FLUID; PLEURA THICKENING; PRIORITY JOURNAL; RETROSPECTIVE STUDY; THORAX RADIOGRAPHY;

EID: 0030663689     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.112.5.1293     Document Type: Article

References (21)

1. American Thoracic Society. Treatment of tuberculosis and tuberculosis infection in adults and children. Am Rev Respir Dis 1994; 149:1359-74
2. Grupo de trabajo sobre tuberculosis. Consenso nacional para el control de la tuberculosis en España. Med Clin (Barc) 1992; 98:24-31
3. Chan CHS, Arnold M, Chan CY, et al. Clinical and pathological features of tuberculous pleural effusion and its long-term consequences. Respiration 1991; 58:171-75
4. Lee CH, Wang WJ, Lan RS, et al. Corticosteroids in the treatment of tuberculous pleurisy: a double-blind, placebo-controlled, randomized study. Chest 1988; 94:1256-59
5. Moudgil H, Sridhar G, Leitch AG. Reactivation disease: the commonest form of tuberculous pleural effusion in Edinburgh, 1980-1991. Respir Med 1994; 88:301-04
6. Soler JJ, Gil Suay V, Cordero P, et al. Corticoides en la tuberculosis pleural i Reducen el engrosamiento pleural residual [abstract]? Arch Bronconeumol 1994; 30(suppl 1):43
7. Galarza I, Cañete C, Granados A, et al. Randomised trial of corticosteroids in the treatment of tuberculous pleurisy. Thorax 1995; 50:1305-07
8. Morrone N, Lombardi MC, Machado O. Prevention of pleural thickening through pleural aspiration in patients with tuberculous effusion. J Pneumol (São Paulo) 1989; 15:180-84
9. Valdes L, San Jose E, Alvarez D, et al. Diagnosis of tuberculous pleurisy using the biologic parameters adenosine deaminase, lysozyme, and interferon gamma. Chest 1993; 103: 458-65
10. Sorribas A, Blanco F, Gómez JA, et al. Adenosina desaminasa: características bioquímicas y significación clínica de una enzima clave para la inmunidad celular. Med Clin (Barc) 1988; 90:548-52
11. Barnes P, Fong S, Brennan P, et al. Local production of tumor necrosis factor and IFN-gamma in tuberculous pleuritis. J Immunol 1990; 145:149-54
12. Light RW. Pleural disease. 3rd ed. Baltimore: Williams & Wilkins, 1990
13. Soler JJ, Gil Suay V, Cordero P, et al. Engrosamiento pleural en el derrame pleural tuberculoso: factores asociados. Arch Bronconeumol 1995; 31:457-61
14. Barbas CS, Cukier A, Varvalho CR, et al. The relationship between pleural fluid findings and the development of pleural thickening in patients with pleural tuberculosis. Chest 1991; 100:1264-67
15. Flores J, Pérez-Rodriguez E, Gaudó J, et al. Valor de la presencia de micobacterias en la tuberculosis pleural. Arch Bronconeumol 1994; 30(suppl 1):38-39
16. Elias JA, Freundlich B, Kern JA, et al. Cytokine networks in the regulation of inflammation and fibrosis in the lung. Chest 1990; 97:1439-45
17. Owens MW, Grimes SR. Pleural mesothelial cell response to inflammation: tumor necrosis factor-induced mitogenesis and collagen synthesis. Am J Physiol 1993; 265(pt 1):L382-88
18. Law K, Weiden M, Harkin T, et al. Increased release of interleukin-1 beta, interleukin-6, and tumor necrosis factor-alpha by bronchoalveolar cells lavaged from involved sites in pulmonary tuberculosis. Am J Respir Crit Care Med 1996; 153:799-804
19. Piguet P, Collart M, Grau G, et al. Tumor necrosis factor/ cachectin plays a key role in bleomycm-induced pneumopathy and fibrosis. J Exp Med 1989; 170:655-63
20. Rook GA, Attiyah R. Cytokines and the Koch phenomenon. Tubercle 1991; 72:13-20
21. Goldstein RH, Fine A. Potential therapeutic initiatives for fibrogenic lung diseases. Chest 1995; 108:848-55